The NIH Clinical Center used to commission artwork for some of their lectures. Here is one for “Phobias and Panic Disorder” from 1985.

📺 Season 2 of The Afterparty was uneven, with a couple of cinematic marvels wedged between a wimpy start and an oddly rushed last episode which seems to have been chopped off at the last minute from the penultimate. The Wes Anderson and Alfred Hitchcock homages in particular were worth bearing the first 60 minutes of Aniq awkwardness.

Phrase of the day: digital dandruff. Thank you, Charlie Warzel.

From the Department of You Can’t Make This Up: the face of D.C. pedestrian safety was hurt in a hit-and-run. And not just a little bit:

Stephen Grasty was placed in a neck brace and taken to George Washington University Hospital, where doctors treated him for a long list of injuries, including a broken leg, foot and vertebra. His C6 vertebra was “hanging on a hair,” Shelly Grasty said.

D.C. could be one of the most pedestrian and bicycle-friendly cities in America (just look at these lanes!), but you just can’t get away from out-of-town drivers. (ᔥAxios)

In retrospect, that friend worried about an eagle flying away with his toddler as prey wasn’t completely bonkers.

I am reluctant to recommend long podcasts, but Joe Walker’s 3+ hour interview with Richard Rhodes, the octogenarian author of The Making of the Atomic Bomb, was so engrossing that I didn’t even realize it was that long until posting this very message. Between discussing the Manhattan project, nuclear energy, AI, and a sprinkling of geopolitics past and present, the conversation just flew by.

From the archive: the author presenting some preclinical work on the cell cycle at the AACR annual meeting in Washington DC, circa 2017. Little did I know that six years later I’d be living just a few blocks down the street.

Derek Lowe writes about a recent Cancer Cell paper pitting glioblastoma cells against each other in a mouse model:

A single clonal line that hit on high Myc expression could outcompete fifteen thousand others from a standing start!

As someone who’s treated patients with Burkitt lymphoma, the Myc-dependent cancer, I can absolutely believe this.